Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_assertion type Assertion NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_head.
- NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_assertion description "[Variations in LH receptor (LHR) and in 5?-reductase II (SRD5A2) genes may modify the effect of TC treatment on testosterone levels, whereas genetic variations in the androgen receptor (AR) may modify the effect on LH levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_provenance.
- NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_assertion evidence source_evidence_literature NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_provenance.
- NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_assertion SIO_000772 25336703 NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_provenance.
- NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_assertion wasDerivedFrom befree-2016 NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_provenance.
- NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_assertion wasGeneratedBy ECO_0000203 NP1231420.RAo_svt3m5nHcgIVxaLpt7bbFEviVhqF4B3uLBLT2aKNQ130_provenance.